Promega

In Vitro Toxicology Testing Market Worth $17.1 billion | MarketsandMarkets

Retrieved on: 
星期五, 十月 27, 2023
MEA, Creative Biolabs, Eurofins Scientific, Pharmacology, Promega, Catalent, Patent, Intertek, Islamic finance products, services and contracts, Food, Charles River Laboratories, LATAM, Toxicology, Genetics, Absorption, Acquisition, Tissue engineering, Maintenance, Research, Protein, Phototoxicity, Software, Metabolism, Drug development, SGS, Growth, Thermo Fisher Scientific, Marketing, Merck Group, Agilent Technologies, Animal, Gene, Corrosion, Safety, Investment, Labcorp, Toxicity, Chemical safety, ADME, Medical device, Pharmaceutical industry, Fine chemical

By product and service, the In vitro toxicology testing market has been further categorized as consumables, assays, equipment, software, and services.

Key Points: 
  • By product and service, the In vitro toxicology testing market has been further categorized as consumables, assays, equipment, software, and services.
  • In 2022, the ADME segment accounted for the largest share of the in vitro toxicology testing market.
  • The pharmaceutical & biopharmaceutical segment accounted for the largest share of the industry segment in the in vitro toxicology testing market in 2022.
  • In 2022, the pharmaceutical & biopharmaceutical industry segment accounted for the largest share of the in vitro toxicology testing market.

In Vitro Toxicology Testing Market Worth $17.1 billion | MarketsandMarkets

Retrieved on: 
星期五, 十月 27, 2023
MEA, Creative Biolabs, Eurofins Scientific, Pharmacology, Promega, Catalent, Patent, Intertek, Islamic finance products, services and contracts, Food, Charles River Laboratories, LATAM, Toxicology, Genetics, Absorption, Acquisition, Tissue engineering, Maintenance, Research, Protein, Phototoxicity, Software, Metabolism, Drug development, SGS, Growth, Thermo Fisher Scientific, Marketing, Merck Group, Agilent Technologies, Animal, Gene, Corrosion, Safety, Investment, Labcorp, Toxicity, Chemical safety, ADME, Medical device, Pharmaceutical industry, Fine chemical

By product and service, the In vitro toxicology testing market has been further categorized as consumables, assays, equipment, software, and services.

Key Points: 
  • By product and service, the In vitro toxicology testing market has been further categorized as consumables, assays, equipment, software, and services.
  • In 2022, the ADME segment accounted for the largest share of the in vitro toxicology testing market.
  • The pharmaceutical & biopharmaceutical segment accounted for the largest share of the industry segment in the in vitro toxicology testing market in 2022.
  • In 2022, the pharmaceutical & biopharmaceutical industry segment accounted for the largest share of the in vitro toxicology testing market.

Promega to Develop Microsatellite Instability (MSI) Companion Diagnostic IVD Kit in Collaboration With GSK

Retrieved on: 
星期二, 十月 3, 2023
Stem Cells, Biotechnology, Other Health, Health, Pharmaceutical, Oncology, Other Science, Research, Genetics, Science, Clinical Trials, Neoplasm, GSK, DNA, Therapy, ICI, Marketing, Microsatellite instability, Cancer, Biomarker, Promega, Corporation, Patient, MSI, Medicine, Mab, IVD, MSI-H, CDX, FDA, NMPA, PCR, ChromeOS, Pharmaceutical industry, EU, Dostarlimab

Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with GSK to identify adult cancer patients with MSI-H solid tumors who may be eligible for potential treatment with GSK’s Jemperli (dostarlimab-gxly).

Key Points: 
  • Promega Corporation today announced it plans to develop and commercialize a microsatellite instability (MSI) companion diagnostic (CDx) IVD kit with GSK to identify adult cancer patients with MSI-H solid tumors who may be eligible for potential treatment with GSK’s Jemperli (dostarlimab-gxly).
  • The collaboration agreement leverages the companies’ complementary strengths to expand personalized healthcare options to more patients using high quality diagnostic tools and treatments.
  • “This collaboration underscores our commitment to enabling patient access to targeted therapies,” says Alok Sharma, Global Clinical Market Director at Promega.
  • Promega has received innovation status and priority review by the NMPA in China and also intends to seek regulatory clearance for a Promega MSI IVD in China.

Global Nucleic Acid Isolation and Purification Market Trends Analysis Report 2023-2030 - ResearchAndMarkets.com

Retrieved on: 
星期三, 九月 20, 2023
Medical Supplies, Biotechnology, Health, Pharmaceutical, Oncology, Other Science, Medical Devices, Infectious Diseases, Hospitals, Genetics, Science, Molecular biology, DNA, NGS, COVID-19, Cancer, Research, Infection, DSM-IV codes, RNA, USD, COVID-19 testing, Promega, Application, Medicine, Growth, Diagnosis, Fungal infection, Massive parallel sequencing, Automation, Fine chemical, Vaccine

The "Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Nucleic Acid Isolation And Purification Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By Method, By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global nucleic acid isolation and purification market size is expected to reach USD 11.21 billion by 2030, expanding at 10.06% CAGR from 2023 to 2030
    The global market for nucleic acid isolation and purification is poised for significant growth, driven by several key factors.
  • The COVID-19 pandemic has had a substantial impact on the demand for nucleic acid isolation and purification processes.
  • This heightened demand has underscored the importance of efficient nucleic acid isolation and purification techniques in the current healthcare landscape.

Advancements in Molecular Diagnostics Fuel Nucleic Acid Isolation Market with 8.5% CAGR Forecast Amid Rising Demand for High-Quality Nucleic Acids - ResearchAndMarkets.com

Retrieved on: 
星期一, 九月 18, 2023
Biotechnology, Pharmaceutical, Genetics, Health, QIAGEN, NGS, Genetic testing, Research, Thermo Fisher Scientific, DSM-IV codes, RNA, Automation, Genomics, Government, DNA, Microfluidics, Compound annual growth rate, Promega, Traction, Investment, Agilent Technologies, Vels Institute of Science, Technology & Advanced Studies, Growth, Robotics, Reagent, Illumina, Inc., Fine chemical, Pharmaceutical industry, Vaccine, Pet industry, Phosphorus, Instrument

The nucleic acid isolation and purification market is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2023 to 2031.

Key Points: 
  • The nucleic acid isolation and purification market is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period from 2023 to 2031.
  • Molecular diagnostic tests for various diseases rely on efficient nucleic acid isolation and purification techniques.
  • Type of Nucleic Acid: Segmented into DNA Isolation & Purification and RNA Isolation & Purification, with RNA purification anticipated to grow rapidly.
  • Key Questions Answered in the Report:
    What factors are impacting the growth of the nucleic acid isolation and purification market?

Promega Fall Art Showcase 2023 to Honor Artist Truman Lowe

Retrieved on: 
星期三, 九月 6, 2023
Other Entertainment, Arts, Museums, Entertainment, Events, Concerts, University, Exhibition, Culture, Beloit College, National Museum of the American Indian, Ho-Chunk, University of Wisconsin–Madison School of Education, Creativity, Emeritus, Lowe, Wood, Promega, Student, Nature, American Indians, Monmouth University Department of Art and Design, Metropolitan, Music, Metropolitan Museum of Art, Interior design, Industrial design, Baking, Native, Art

The Promega Fall Art Showcase will honor the life of Truman Lowe, a visionary artist, mentor and art professor.

Key Points: 
  • The Promega Fall Art Showcase will honor the life of Truman Lowe, a visionary artist, mentor and art professor.
  • Truman Lowe was an acclaimed Ho-Chunk artist and professor in the Department of Art at the University of Wisconsin-Madison for 45 years.
  • The Fall Art Showcase will honor the legacy of Truman Lowe by exhibiting his art alongside pieces by several former students: Sarah McRae, Karen Goulet, Chloris Lowe, Tom Jones, Jo Fedderson and John Hitchcock.
  • Learn more about the Promega Art Showcase here , Promega Corporation here and the company’s larger corporate responsibility story here .

Driving Precision Medicine: Rising Demand for Single Cell Analysis Propels Global Market Growth to 2028 - ResearchAndMarkets.com

Retrieved on: 
星期二, 九月 5, 2023
COVID-19, Research, Genetics, Diabetes, Cardiology, Stem Cells, Biotechnology, Health, Science, Oncology, Bio-Rad Laboratories, Prevalence, Investment, SARS-CoV-2, Genomics, Cancer, Single-cell analysis, Medicine, Cell, Danaher Corporation, Competition, Becton, Dickinson and Company headquarters, Huntingdon, Compound annual growth rate, Neuroscience, Promega, NHLBI, HIV disease progression rates, Thermo Fisher Scientific, Application, Chronic condition, Consumables, Flow cytometry, Conditional sentence, Growth, Merck, Mindful Scientific Inc., Safety, Disease, Government, Pharmaceutical industry, Vaccine, Medical imaging, Illumina

The Global Single Cell Analysis Market is expected to experience substantial growth with a steady Compound Annual Growth Rate (CAGR) during the period of 2024 to 2028.

Key Points: 
  • The Global Single Cell Analysis Market is expected to experience substantial growth with a steady Compound Annual Growth Rate (CAGR) during the period of 2024 to 2028.
  • The growth of genomic and proteomic technologies has significantly influenced the expansion of the global single cell analysis market.
  • Chronic diseases, including cancer, cardiovascular conditions, and diabetes, are significant drivers of the global single cell analysis market.
  • Government funding plays a pivotal role in the growth of the global single cell analysis market.

CRISPR-Cas9 Knock-In Efficiency Enhanced Using Small-Molecule Inhibitor Pair, Study Shows

Retrieved on: 
星期一, 八月 21, 2023
Research, Genetics, Clinical Trials, Stem Cells, Biotechnology, Other Health, Health, Other Science, Science, Theta, Cas9, NGS, DNA, CRISPR, Nature Communications, DNA polymerase, Biomedical Research, Protein, Promega, AstraZeneca, Vaccine

A new study published in Nature Communications demonstrates how small molecule inhibitors can be used to improve the precision and efficiency of CRISPR-Cas9 gene editing.

Key Points: 
  • A new study published in Nature Communications demonstrates how small molecule inhibitors can be used to improve the precision and efficiency of CRISPR-Cas9 gene editing.
  • The results demonstrate how this groundbreaking technique can be enhanced by using two inhibitors to boost insertion rates and reduce off-target effects.
  • Their findings are key to advancing the use of CRISPR techniques in research and clinical applications using a wide range of cell lines.
  • This strategy, dubbed 2iHDR, outperformed previously described strategies that aimed to increase knock-in efficiency with small molecule inhibitors.

Promega and BTC Institute D.O.O.R.S Scholarship Recognizes STEM Students from Underrepresented Backgrounds

Retrieved on: 
星期一, 八月 14, 2023
Green Technology, Other Health, Environment, Other Science, Pharmaceutical, Research, Other Technology, Mental Health, Science, Technology, General Health, Biotechnology, Neurology, Agriculture, Natural Resources, Health, University, Primary, Secondary, Education, Student, BTC, Multimedia, Mentorship, Book, Management, Promega

Scholarship aims to recognize and empower students from underrepresented backgrounds who are pursuing a biotechnology-related major.

Key Points: 
  • Scholarship aims to recognize and empower students from underrepresented backgrounds who are pursuing a biotechnology-related major.
  • The scholarship is offered by Promega Corporation and the BioPharmaceutical Technology Center Institute (BTC Institute).
  • Scholarship recipients will receive $5,000 that can be used toward fees, books, supplies and equipment required for their scientific courses.
  • Applications are open to undergraduate students from underrepresented backgrounds pursuing a biotechnology-related major.

DNA-Encoded Libraries (DELs) and NanoBRET Target Engagement Assays Accelerate Drug Discovery

Retrieved on: 
星期二, 八月 1, 2023
Biotechnology, Other Health, Health, Science, Research, DNA, Partnership, Therapy, Aurora kinase A, Workflow, Cell Chemical Biology, Dels, Structural Genomics Consortium, Promega, Protein, DEL, Cancer, Drug discovery, Wuxi, Pharmaceutical industry, Microscope

A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery.

Key Points: 
  • A new study demonstrates how the combination of DNA-encoded libraries (DELs) and NanoBRET Target Engagement technology can accelerate early-stage drug discovery.
  • This research opens new opportunities to develop novel NanoBRET Target Engagement Assays aimed at many understudied classes of proteins, rapidly accelerating “hit to lead” efforts in identifying new potential therapeutics.
  • These probes would be used in a NanoBRET Target Engagement Assay, a tool for studying the interaction between a chemical compound and its target protein in live cells.
  • Additionally, they note that the NanoBRET assays help drug discovery researchers accelerate their workflow by providing data used to identify the most promising leads.